(Ra,S,S)-SpiroBOX
Modify Date: 2024-01-11 18:21:01
(Ra,S,S)-SpiroBOX structure
|
Common Name | (Ra,S,S)-SpiroBOX | ||
|---|---|---|---|---|
| CAS Number | 890090-21-8 | Molecular Weight | 510.62500 | |
| Density | 1.29±0.1 g/cm3 | Boiling Point | 712.1±60.0 °C | |
| Molecular Formula | C35H30N2O2 | Melting Point | 130-132 °C | |
| MSDS | N/A | Flash Point | N/A | |
| Name | (4S)-4-phenyl-2-[4'-[(4S)-4-phenyl-4,5-dihydro-1,3-oxazol-2-yl]-3,3'-spirobi[1,2-dihydroindene]-4-yl]-4,5-dihydro-1,3-oxazole |
|---|---|
| Synonym | More Synonyms |
| Density | 1.29±0.1 g/cm3 |
|---|---|
| Boiling Point | 712.1±60.0 °C |
| Melting Point | 130-132 °C |
| Molecular Formula | C35H30N2O2 |
| Molecular Weight | 510.62500 |
| Exact Mass | 510.23100 |
| PSA | 43.18000 |
| LogP | 5.77250 |
| Storage condition | 2-8°C |
|
Section 1: Product Identification Chemical Name:(R)-7,7’-Bis[(4S)-(phenyl)oxazol-2-yl)]-2,2’,3,3’-tetrahydro-1,1’-spirobiindane, min. 97% (Ra,S,S)-SpiroBOX CAS Registry Number:890090-21-8 Formula:C35H30N2O2 EINECS Number:none Chemical Family:organic amine Synonym:(Ra,S,S)-SpiroBOX
Section 2: Composition and Information on Ingredients IngredientCAS NumberPercentACGIH (TWA)OSHA (PEL) Title compound890090-21-8100%no datano data Section 3: Hazards Identification Emergency Overview:Irritating to skin, eyes and respiratory tract. Primary Routes of Exposure:Ingestion, inhalation, eyes Eye Contact:Causes slight to mild irritation of the eyes. Skin Contact:Causes slight to mild irritation of the skin. Inhalation:Irritating to the nose, mucous membranes and respiratory tract. Ingestion:No information available on the physiological effects of ingestion. May be harmful if swallowed. Acute Health Affects:Irritating to skin, eyes and respiratory tract. Chronic Health Affects:No information on long-term chronic effects. NTP:No IARC:No OSHA:No SECTION 4: First Aid Measures Immediately flush the eyes with copious amounts of water for at least 10-15 minutes. A victim may need Eye Exposure: assistance in keeping their eye lids open. Get immediate medical attention. Wash the affected area with water. Remove contaminated clothes if necessary. Seek medical assistance if Skin Exposure: irritation persists. Remove the victim to fresh air. Closely monitor the victim for signs of respiratory problems, such as difficulty Inhalation: in breathing, coughing, wheezing, or pain. In such cases seek immediate medical assistance. Seek medical attention immediately. Keep the victim calm. Give the victim water (only if conscious). Induce Ingestion: vomiting only if directed by medical personnel. SECTION 5: Fire Fighting Measures Flash Point:none Autoignition Temperature:none Explosion Limits:none Extinguishing Medium:carbon dioxide, dry powder or foam If this product is involved in a fire, fire fighters should be equipped with a NIOSH approved positive pressure Special Fire Fighting Procedures: self-contained breathing apparatus and full protective clothing. Hazardous Combustion andIf involved in a fire this material may emit irritating fumes. Decomposion Products: Unusual Fire or Explosion Hazards: No unusual fire or explosion hazards. SECTION 6: Accidental Release Measures Spill and Leak Procedures:Small spills can be mixed with vermiculite or sodium carbonate and swept up. SECTION 7: Handling and Storage Store in a tightly sealed container under an inert atmosphere of nitrogen or argon. Keep in a cool, dry, Handling and Storage: well-ventilated place. SECTION 8: Exposure Controls and Personal Protection Eye Protection:Always wear approved safety glasses when handling a chemical substance in the laboratory. Skin Protection:Wear protective clothing and gloves. Ventilation:Handle the material in an efficient fume hood. If ventilation is not available a respirator should be worn. The use of respirators requires a Respirator Respirator: Protection Program to be in compliance with 29 CFR 1910.134. Ventilation:Handle the material in an efficient fume hood. Additional Protection:No additional protection required. SECTION 9: Physical and Chemical Properties Color and Form:white solid Molecular Weight:510.62 Melting Point:130-132 ° Boiling Point:no data Vapor Pressure:no data Specific Gravity:no data Odor:none Solubility in Water:insoluble SECTION 10: Stability and Reactivity Stability:moisture sensitive Hazardous Polymerization:no hazardous polymerization Conditions to Avoid:exposure to moisture Incompatibility:strong oxidizing agents Decomposition Products:carbon monoxide, carbon dioxide, nitrogen oxides, and organic fumes SECTION 11: Toxicological Information RTECS Data:No information available in the RTECS files. Carcinogenic Effects:no data Mutagenic Effects:no data Tetratogenic Effects:no data SECTION 12: Ecological Information Ecological Information:No information available SECTION 13: Disposal Considerations Disposal:Dispose of according to local, state and federal regulations. SECTION 14: Transportation Shipping Name (CFR):Non-hazardous Hazard Class (CFR):NA Additional Hazard Class (CFR):NA Packaging Group (CFR):NA UN ID Number (CFR):NA Shipping Name (IATA):Non-hazardous Hazard Class (IATA):NA Additional Hazard Class (IATA):NA Packaging Group (IATA):NA UN ID Number (IATA):NA SECTION 15: Regulatory Information TSCA:Not listed in the TSCA inventory SARA (Title 313):Not regulated under SARA 313 Second Ingredient:none SECTION 16 - ADDITIONAL INFORMATION N/A |
| Hazard Codes | Xi |
|---|
| (Ra)-7,7'-Bis((S)-4-phenyl-4,5-dihydrooxazol-2-yl)-1,1'-spirobiindane |
| (Ra,S,S)-7,7 inverted exclamation marka-bis(4 inverted exclamation marka-phenyloxazol-2-yl)-1,1 inverted exclamation marka-spirobiindane |
| (Sa)-7,7'-Bis((S)-4-phenyl-4,5-dihydrooxazol-2-yl)-1,1'-spirobiindane |